Marijke Stigter-van Walsum Selected Research

Marijke Stigter-van Walsum Research Topics

Disease

24	Neoplasms (Cancer) 10/2021 - 03/2003
6	Head and Neck Neoplasms (Head and Neck Cancer) 10/2021 - 08/2003
6	Squamous Cell Carcinoma of Head and Neck 06/2019 - 03/2003
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2015 - 04/2013
2	Lung Neoplasms (Lung Cancer) 01/2015 - 10/2014
1	Glioblastoma (Glioblastoma Multiforme) 04/2012
1	Stomach Neoplasms (Stomach Cancer) 10/2008
1	Neoplasm Metastasis (Metastasis) 10/2008
1	Acquired Immunodeficiency Syndrome (AIDS) 10/2007
1	Residual Neoplasm 10/2007
1	Leukemia 10/2007

Drug/Important Bio-Agent (IBA)

5	Cetuximab (Erbitux)FDA Link 10/2021 - 11/2005
4	ErbB Receptors (EGF Receptor)IBA 01/2015 - 07/2006
4	Monoclonal AntibodiesIBA 10/2014 - 08/2003
3	Pharmaceutical PreparationsIBA 11/2019 - 10/2014
3	Single-Domain AntibodiesIBA 10/2013 - 08/2008
2	RNA (Ribonucleic Acid)IBA 06/2019 - 10/2013
2	Small Interfering RNA (siRNA)IBA 06/2015 - 04/2013
2	Tyrosine Kinase InhibitorsIBA 01/2015 - 05/2013
2	AfatinibIBA 01/2015 - 10/2014
2	Chemokine ReceptorsIBA 10/2013 - 04/2009
2	AntigensIBA 10/2007 - 03/2003
2	(124)I-cMAb U36IBA 08/2003 - 08/2003
1	Neoplasm Antigens (Tumor Antigens)IBA 10/2021
1	LigandsIBA 10/2021
1	Toll-Like Receptor 2IBA 10/2021
1	LY2603618IBA 06/2019
1	MicroRNAs (MicroRNA)IBA 06/2019
1	Checkpoint Kinase 1IBA 06/2019
1	adavosertibIBA 06/2019
1	Polo-Like Kinase 1IBA 11/2017
1	tariquidar (XR9576)IBA 01/2015
1	Glycoproteins (Glycoprotein)IBA 01/2015
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2015
1	Ado-Trastuzumab EmtansineIBA 10/2014
1	TUB-OMOM-trastuzumabIBA 10/2014
1	Trastuzumab (Herceptin)FDA Link 10/2014
1	Peptides (Polypeptides)IBA 10/2014
1	Indicators and Reagents (Reagents)IBA 10/2014
1	Fluorine-18IBA 10/2014
1	RG7356IBA 03/2014
1	Chemokine CXCL1IBA 10/2013
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2013
1	Sorafenib (BAY 43-9006)FDA Link 05/2013
1	Antineoplastic Agents (Antineoplastics)IBA 04/2013
1	ispinesibIBA 04/2013
1	Zirconium-89IBA 04/2012
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 04/2012
1	Proteins (Proteins, Gene)FDA Link 02/2012
1	Fluorescent Dyes (Fluorescent Probes)IBA 12/2011
1	Coloring Agents (Dyes)IBA 12/2011
1	AzidesIBA 10/2011
1	phosphine (phosphane)IBA 10/2011
1	Trichlormethiazide (Naqua)FDA Link 10/2011
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2009
1	Celecoxib (Celebrex)FDA Link 04/2009
1	IodineIBA 10/2008
1	AlbuminsIBA 08/2008
1	Fibronectins (Fibronectin)IBA 07/2006
1	Radioisotopes (Radionuclides)IBA 11/2005
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 08/2003
1	Immunoconjugates (Immunoconjugate)IBA 08/2003

Therapy/Procedure

6	Therapeutics 10/2021 - 03/2003
3	Radioimmunotherapy 07/2006 - 08/2003
2	Radiotherapy 06/2015 - 05/2013
2	Drug Therapy (Chemotherapy) 05/2013 - 10/2007
1	Immunotherapy 10/2021
1	Ligation 10/2011